In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 11 to 16 of 16

TitleConsultationTypeConsultation end date
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and over ID6542Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Guidance on the use of electroconvulsive therapyReview proposal consultationTechnology appraisal guidance
Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people 1 year and over ID6400Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Pharmalgen for the treatment of bee and wasp venom allergyReview proposal consultationTechnology appraisal guidance
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphomaReview proposal consultationTechnology appraisal guidance
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369]Final draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All